CCEL insider trading
NYSE American HealthcareCRYO CELL INTERNATIONAL INC: insider trade history from SEC Form 4 filings.
About CRYO CELL INTERNATIONAL INC
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Company website: www.cryo-cell.com
CCEL insider activity at a glance
FilingIQ tracks 356 insider transactions for CCEL in filings since Jan 21, 2015. The most recent transaction is dated Aug 5, 2026.
Across the full history, 229 open-market purchases
and 47 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CCEL insider trades is 56.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CCEL Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CCEL?
- FilingIQ tracks 356 Form 4 insider transactions for CCEL (CRYO CELL INTERNATIONAL INC), covering filings from Jan 21, 2015 onwards. 2 of those are dated within the last 90 days.
- Are CCEL insiders net buyers or net sellers?
- Across the full Form 4 history for CCEL, 229 transactions (64%) were open-market purchases and 47 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CCEL insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CCEL in?
- CRYO CELL INTERNATIONAL INC (CCEL) is classified in the Healthcare sector, specifically Medical Care Facilities, with a current market capitalisation of $27.39M.
Methodology & sources
Every CCEL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.